Cite
HARVARD Citation
Soumerai, J. et al. (2019). Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations. Lancet. 6 (7), pp. e366-e374. [Online].